摘要
目的研究参苓白术散联合美沙拉嗪治疗脾胃气虚型溃疡性结肠炎的疗效。方法将我院2009年2月～2013年3月间住院治疗的脾胃气虚型溃疡性结肠炎96例患者分成正常组和对照组各48例，正常组给予美沙拉嗪治疗，对照组给予参苓白术散联合美沙拉嗪治疗，比较两组疗效。结果对照组治疗效果良好的有32例（占66．67％），远远优于正常组的14例（占29．17％），对照组治疗效果的显效率为87．50％，明显高于正常组68．75％的显效率，两组比较差异有统计学意义（P〈0．05）。结论参苓白术散联合美沙拉嗪对于脾胃气虚型溃疡性结肠炎患者的治疗效果显著、不良反应少，值得临床推广应用。
Objective To study the clinical effect of Shenlinghaixhu powder combined with mesalazine treating uleerative colitis of spleen stomach qi deficiency. Methods 96 patients with ulcerative colitis of spleen stomach qi deficieney treated in our hospital from February 2009 to March 2013 were divided into the regular group（48 patients） and the control group（48 patients）. Patients in the regular group were treated with mcsalazine sustained-release tablets. Patients in the control group were treated with Shenlinghaizhu powder eombined with mesalazine. The Curative effects between the two groups were compared and analysed. Results There were 32 （66.67%）patients in the control group whose curative effects were good, The rate was significantly higher than that in the regular group [ 14/48（29.17%）]. The effective rate of the control group was 87.50%, significantly higher than 68.75% of the regular group. There was statistical difference （P 〈 0.05）. Conclusion Shenlinghaizhu powder combined with mesalazine treating ulcerative colitis of spleen stomach qi deficiency has signifieantly curative effect and has fewer adverse reactions. It is worth of further popularization and application.
出处
《中国医药科学》
2013年第17期120-121,共2页
China Medicine And Pharmacy
关键词
参苓白术散
美沙拉嗪
脾胃气虚型溃疡性结肠炎
缓释颗粒
Shenlinghaizhu powder
Mesalazine
Uleerative colitis of spleen stomach qi deficiency
Slow-release granule
